Clinical Trial Results TV

Main Menu

Series

Duke Clinical Medicine
SCAI TV

Categories


	Trial / Study: 1047 submissions (showing 1 to 15)

| Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 | Page 16 | Page 17 | Page 18 | Page 19 | Page 20 | Page 21 | Page 22 | Page 23 | Page 24 | Page 25 | Page 26 | Page 27 | Page 28 | Page 29 | Page 30 | Page 31 | Page 32 | Page 33 | Page 34 | Page 35 | Page 36 | Page 37 | Page 38 | Page 39 | Page 40 | Page 41 | Page 42 | Page 43 | Page 44 | Page 45 | Page 46 | Page 47 | Page 48 | Page 49 | Page 50 | Page 51 | Page 52 | Page 53 | Page 54 | Page 55 | Page 56 | Page 57 | Page 58 | Page 59 | Page 60 | Page 61 | Page 62 | Page 63 | Page 64 | Page 65 | Page 66 | Page 67 | Page 68 | Page 69 | Page 70 |

Dr. John Spertus and Dr. Adam T Phillips Discuss: International Study of Comparative Health Effectiveness With Medical a
Dr. John Spertus

Dr. Roxana Mehran, Dr. Christopher Granger, Dr. Gabriel Steg and Dr. C. Michael Gibson Discuss: Antiplatelet Therapy in
Dr. Roxana Mehran, Dr. P. Gabriel Steg, Dr. Christopher Granger, Dr. C. Michael Gibson

Dr. Kevin Bainey and Dr. Robert Welsh Present: AHA 2019 Wrap-Up from the Canadian Perspective
Dr. Kevin Bainey, Dr. Robert Welsh

Dr. Renato Lopes and Dr. Roberto Giraldez Present: AHA 2019 Wrap-Up in Portuguese
Dr. Renato Lopes, Dr. Roberto Giraldez

Dr. Pierre Amarenco and Dr. Adam T Phillips Discuss: Benefit of a Target LDL Cholesterol Less Than 70 mg/dl After an Isc
Dr. Pierre Amarenco

Dr. Christie Ballantyne and Dr. Adam T Phillips Discuss: ASCVD Reduction and Lipid Lowering Therapies
Dr. Christie Ballantyne

Dr. Ann Marie Navar and Dr. C. Michael Gibson Discuss: The Ongoing Battle of Adherence - Sponsored by an independent edu
Dr. Ann Marie Navar

Dr. Jennifer Robinson and Dr. C.Michael Gibson Discuss: The Evolving Landscape of PCSK9 Inhibitors
Dr. Jennifer Robinson

Prof. Philip Aylward Presents: AHA 2019 Wrap-Up from the Perspective of the Pacific Rim
Dr. Philip Aylward

Ms. Katherine Wilemon, Founder and CEO of the FH Foundation, and Dr. C. Michael Gibson Discuss: Familial Hypercholestero
Ms. Katherine Wilemon

Dr. George Dangas and Dr. C. Michael Gibson Discuss: GALILEO: Global Comparison of a Rivaroxaban-Based Antithrombotic St
Dr. George Dangas

Dr. Matthew Budoff and Dr. C Michael Gibson Discuss: EVAPORATE Study: Effect of Icosapent Ethyl on Progression of Corona
Dr. Matthew Budoff

Dr. Sripal Bangalore and Dr. C Michael Gibson Discuss: International Study of Comparative Health Effectiveness With Medi
Dr. Sripal Bangalore

Dr. Kausik Ray and Dr. C Michael Gibson Discuss: BETonMACE: Effect of BET Protein Inhibition With Apabetalone on Cardiov
Dr. Kausik Ray

Dr. Natalia Pinilla-Echeverri and Dr. Arzu Kalayci: COMPLETE: Non-Culprit Lesion Plaque Morphology in Patients With ST-S
Dr. Natalia Pinilla-Echeverri